Navigation Links
Volcano Reports Record Revenue and GAAP Profitability for 2010
Date:2/23/2011

SAN DIEGO, Feb. 23, 2011 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, today reported record revenues for the fourth quarter and all of fiscal 2010.

For the quarter ended December 31, 2010, Volcano reported revenues of $81.2 million, compared to revenues of $71.0 million in the fourth quarter of fiscal 2009. Revenues in the fourth quarter of 2010 were negatively impacted by approximately $3.0 million related to the transition of a distributor relationship in Japan. Revenues in the fourth quarter of 2009 were favorably impacted by the first full quarter of a direct sales program in Japan resulting from the company’s transition of a distribution agreement with its largest distributor in the market.

The company reported a net loss on a GAAP basis of $1.7 million, or $0.03 per share, in the fourth quarter of 2010, versus a net loss on a GAAP basis of $12.1 million, or $0.25 per share, in the fourth quarter of 2009. Included in the results for the fourth quarter of 2010 are  expenses of $4.9 million related to the LightLab Imaging, Inc. trade secrets litigation and our litigation costs of $2.8 million. These were partially offset by a reversal of a $3.0 million accrual for a milestone payment related to the Novelis, Inc. acquisition. Included in the results for the fourth quarter of 2009 are in-process research and development charges of $14.0 million resulting from accrued milestone payments related to the CardioSpectra, Inc., and Novelis, Inc., acquisitions.

Excluding stock-based compensation expense of $3.2 million, the in-process research and development benefit of $3.0 million and the LightLab trade secrets litigation expense of $4.9 million, Volcano reported non-GAAP
'/>"/>

SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
2. Final Superior Court Ruling on Trade Secret Lawsuit Favors Volcano Corporation and Its Axsun Subsidiary
3. Massachusetts Court Rules in Favor of Volcano and Against St. Jude Medical Subsidiary in Trade Secrets Case
4. Volcano Reports 35 Percent Increase in Third Quarter Revenues; Records $9.6 Million Improvement in Year-Over-Year GAAP Profitability
5. Volcano Drives Innovation Forward With Three New U.S. Product Launches at TCT 2010
6. Volcano Announces It Will End Distribution Agreement with Fukuda; Transition Enhances Companys Direct Selling Program in Japan
7. Volcano Corporation Files Counterclaim Asserting St. Jude Infringes Three Volcano Patents; Answers St. Judes Patent Infringement Claims
8. Volcano Corporation Prices $100 Million 2.875 Percent Convertible Senior Notes Due 2015
9. Volcano Corporation to Offer $100 Million Convertible Senior Notes Due 2015
10. Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast
11. Volcano Will Strongly Defend Against St. Jude Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... Research and Markets ( ... "Global Smart Wearable Healthcare Devices and Services ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The analysts forecast ... market to grow at a CAGR of 30.42% ... covers the present scenario and the growth prospects ...
(Date:3/26/2015)... Md. , March 26, 2015  RegeneRx Biopharmaceuticals, ... it has received a patent acceptance notice from the ... 4 (TB4) to prevent or reduce tissue damage caused ... the case when cardiac vessels are opened after a ... when treating stroke victims. Damage can be ...
(Date:3/26/2015)...  Becton, Dickinson and Company (NYSE: BDX ) ... exchange all validly tendered and accepted notes of the ... subsidiary of BD, for notes to be issued by ... Statement on Form S-4 (the "Registration Statement") relating to ... the Securities and Exchange Commission ("SEC") on March 26, ...
Breaking Medicine Technology:Global Smart Wearable Healthcare Devices and Services Market 2015-2019 WITH Apple, At&T, Ee, Google, Samsung, Sprint, Telefonica & T-Mobile Dominating 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3Becton, Dickinson and Company to Commence Exchange Offers 2Becton, Dickinson and Company to Commence Exchange Offers 3Becton, Dickinson and Company to Commence Exchange Offers 4Becton, Dickinson and Company to Commence Exchange Offers 5
... 7, 2011 Intellect Neurosciences, Inc. (OTCBB: ILNS) a ... and multiple licenses with major pharmaceutical companies covering products ... Dr. Daniel Chain, Ph.D., Chairman and CEO will be ... Dr. Chain will be discussing the state of the ...
... The U.S. Food and Drug Administration and the ... a "parallel review" pilot program for concurrent review of ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... today, issued procedures for voluntary participation and guiding principles ...
Cached Medicine Technology:Intellect Neurosciences CEO to be Featured on Wall Street Reporter 2FDA, CMS Launch Pilot Program for Voluntary Parallel Review of Innovative Devices 2
(Date:3/26/2015)... Dr. Rod J. Rohrich, who served as ... and has trained over 6500 surgeons through these meetings ... medicine (EBM), that is, the optimization of decision making ... often hear from rhinoplasty surgeons who describe ... not trying to stifle these discussions, we do want ...
(Date:3/26/2015)... UC Davis will establish a prestigious, leading-edge center ... A Silvio O. Conte Center for Basic or Translational ... the United States. , The center will be funded ... of Mental Health, which will allow UC Davis’ Conte ... of schizophrenia may be dysregulation of immune molecules that ...
(Date:3/26/2015)... Scott Sullivan and Frank DellaCroce, Co-Founders of the ... St. Charles Surgical Hospital (SCSH) in New ... Oncologist Dr. William Karl Ordoyne has joined their highly ... oncologist Alan Stolier, M.D., FACS and the team of ... M.D., FACS; Chris Trahan, M.D., FACS; M. Whitten Wise, ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Building ... of continuing medical education, the Cardiometabolic Risk ... Medicine at Tulane University are proud to ... Medicine. The interdisciplinary program , which ... credential, is designed for physicians, nurse practitioners, physician ...
(Date:3/26/2015)... March 26, 2015 Visiting Nurse ... their 18th annual gala fundraiser, Lighting the Way, Brightening ... p.m. at The Madison Hotel in Morristown, NJ. ... entertainment by renowned musician Rio Clemente, delightful cuisine, an ... and Dave Hertzel. Additionally, two prestigious awards will be ...
Breaking Medicine News(10 mins):Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 3Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 4Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 3Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 3Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2
... Human ... , , ... (PRWEB) April 6, 2010 -- Human Touch , the U.S. market leader of innovative ... the World Federation of Chiropractic (WFC) for its massage chairs as a valid supplement to ...
... (short for sarcoma) is a family of proto-oncogenic tyrosine ... the most common malignant cancer in children. Src represents ... A recent study shows that pyrazolo-[3,4-d]pyrimidine-derivatives, designed to ... cell cycle and causing cancer cell death in medulloblastoma. ...
... Swedish medical university Karolinska Institutet provides evidence that basic ... that also exist in the most primitive vertebrates, such ... an investigation into the limbic striatum, one of the ... to learn movements, consciously and unconsciously, through repetition. ...
... ... massage. There are many other massages and spa services that customers can enjoy ... ... Envy’s New Jersey franchise group ( http://www.massageenvy.com/regions/NJ/Northern-New-Jersey.aspx ), a subsection of franchisees of ...
... and sedatives up 65 percent in U.S., study finds ... by accidental and intentional abuse of prescription sedatives, tranquilizers ... last decade, new research reveals. , Hospital stays from ... Percocet) and sedatives (such as Valium and Ativan) jumped ...
... ... ... Noni International (TNI) announced a new quarter of a million dollar challenge to all ... industry will measure up to Tahitian Noni Bioactive Beverages., , , , ,Tahitian Noni International ...
Cached Medicine News:Health News:Human Touch Massage Chairs Receive Exclusive Endorsement from World Federation of Chiropractic 2Health News:Human Touch Massage Chairs Receive Exclusive Endorsement from World Federation of Chiropractic 3Health News:Human Touch Massage Chairs Receive Exclusive Endorsement from World Federation of Chiropractic 4Health News:Human Touch Massage Chairs Receive Exclusive Endorsement from World Federation of Chiropractic 5Health News:New pyrimidine compounds may lead to improved treatments for childhood brain cancer 2Health News:Unconscious learning uses old parts of the brain 2Health News:Massage Envy New Jersey offers $49, 1-Hour Therapeutic Massage 2Health News:Prescription Drug Abuse Sending More to Hospitals 2Health News:Prescription Drug Abuse Sending More to Hospitals 3Health News:Quarter of a Million Dollar Superfruit Challenge Announced 2
Used as a percutaneous entry needle to introduce wire guides. The coaxial design reduces potential A.V. malformations. Supplied sterile in peel-open packages. Intended for one-time use....
Used under fluoroscopy for initial location and positioning of the renal collecting system throughout a percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
Used under fluoroscopy for initial location and positioning of the renal collecting system throughout a percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
Medicine Products: